Addressing cardiometabolic risk in adults with spinal cord injury: acting now despite knowledge gaps.
Cardiovascular diseases
Risk factors
Spinal cord diseases
Journal
Spinal cord series and cases
ISSN: 2058-6124
Titre abrégé: Spinal Cord Ser Cases
Pays: England
ID NLM: 101680856
Informations de publication
Date de publication:
2019
2019
Historique:
received:
10
10
2019
accepted:
25
10
2019
entrez:
5
12
2019
pubmed:
5
12
2019
medline:
20
9
2020
Statut:
epublish
Résumé
This perspective advocates for the adoption of recently published clinical practice guidelines on identifying and managing cardiometabolic risk after spinal cord injury (SCI). It makes the case for acting now, with the knowledge that we currently have, while continuing to address knowledge gaps with high-quality research studies in this area. Cardiovascular disease is a leading cause of death in people with SCI. Cardiometabolic disease (CMD) and risks are more likely to be overlooked after SCI. Unique SCI-related considerations impact both assessment and management of cardiometabolic risk. Risk factors and components of CMD including obesity, impaired glucose tolerance/insulin resistance, dyslipidemia, and hypertension should be evaluated and managed to optimize the cardiometabolic health of this population. While it would be optimal to base all care on high-quality evidence-based research, its absence should not be an excuse for inaction. Applying what is currently known and filling the research gaps with empirical recommendations based on clinical rationale and expert consensus is both appropriate and necessary till more definitive SCI-specific evidence becomes available.
Identifiants
pubmed: 31798971
doi: 10.1038/s41394-019-0241-5
pii: 10.1038/s41394-019-0241-5
pmc: PMC6881335
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
96Informations de copyright
© Crown 2019.
Déclaration de conflit d'intérêts
Conflict of interestThe author declares that he has no conflict of interest.
Références
J Rehabil Med. 2010 May;42(5):489-92
pubmed: 20544162
J Neurotrauma. 2015 Dec 15;32(24):1927-42
pubmed: 25962761
Spinal Cord. 1999 Sep;37(9):601-16
pubmed: 10490851
J Am Paraplegia Soc. 1990 Oct;13(4):63-71
pubmed: 2258731
Top Spinal Cord Inj Rehabil. 2013 Summer;19(3):183-94
pubmed: 23960702
Evid Rep Technol Assess (Full Rep). 2008 Jan;(163):1-95
pubmed: 18457480
Spinal Cord. 2012 May;50(5):373-8
pubmed: 22143678
Neurology. 2013 Nov 19;81(21):1864-8
pubmed: 24153440
Spinal Cord. 2000 Oct;38(10):604-10
pubmed: 11093321
Top Spinal Cord Inj Rehabil. 2013 Summer;19(3):172-82
pubmed: 23960701
J Spinal Cord Med. 2018 Jan;41(1):2-9
pubmed: 27077567
Am J Phys Med Rehabil. 2008 Jul;87(7):545-55
pubmed: 18574346
Arch Phys Med Rehabil. 2000 Apr;81(4):506-16
pubmed: 10768544
Int Heart J. 2006 May;47(3):325-30
pubmed: 16823238
Spinal Cord. 2005 Jul;43(7):408-16
pubmed: 15711609
Arch Phys Med Rehabil. 1994 Sep;75(9):946-50
pubmed: 8085927
J Am Diet Assoc. 1981 May;78(5):501-5
pubmed: 7252010
Arch Phys Med Rehabil. 1992 Jan;73(1):91-4
pubmed: 1729981
Med Sci Sports Exerc. 1993 Apr;25(4):433-41
pubmed: 8479297
Phys Med Rehabil Clin N Am. 2014 Aug;25(3):573-604, viii
pubmed: 25064789
Top Spinal Cord Inj Rehabil. 2012 Fall;18(4):354-78
pubmed: 23459498
Neurology. 2013 Aug 20;81(8):723-8
pubmed: 23884034
Curr Opin Clin Nutr Metab Care. 2004 Nov;7(6):635-9
pubmed: 15534431
Clin Diabetes. 2018 Jan;36(1):14-37
pubmed: 29382975
Arch Phys Med Rehabil. 2012 Jan;93(1):90-5
pubmed: 22200386
Top Spinal Cord Inj Rehabil. 2018 Fall;24(4):379-423
pubmed: 30459501
Arch Phys Med Rehabil. 2016 Oct;97(10):1696-705
pubmed: 27465752
Phys Med Rehabil Clin N Am. 2007 May;18(2):333-51, vii
pubmed: 17543776
J Spinal Cord Med. 2001 Winter;24(4):266-77
pubmed: 11944785
J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):479-82
pubmed: 6618941
Circulation. 2019 Sep 10;140(11):e596-e646
pubmed: 30879355
Top Spinal Cord Inj Rehabil. 2007 Summer;13(1):98-122
pubmed: 22719205